提示：

1、投稿方式：在线投稿。

2、期刊网址：

https://www.cell.com/molecular-therapy-family/home

3、投稿网址：

https://www.editorialmanager.com/molecular-therapy/

4、官网邮箱：如下。

5、期刊刊期：月刊，一年出版十二期。

2021年5月22日星期六

期刊邮箱【官网信息】

Molecular Therapy

Editor-in-Chief

Roland W. Herzog, PhD

Professor of Pediatrics

Riley Children’s Foundation Professor of Immunology

Director, Gene and Cell Therapy Program

Herman B Wells Center for Pediatric Research

Indiana University

Indianapolis, IN 46202

Email: rwherzog@iu.edu

Executive Editor

Robert M Frederickson, PhD

Molecular Therapy Editorial Office

710 Summit Avenue East

Seattle, WA 98102

Tel: +1 323-989-7070

Email: editor@molther.org

Editorial Office

Editorial Questions: editor@molther.org

Technical Questions: journals@asgct.org

投稿须知【官网信息】

Molecular Therapy

Information for Authors

This page describes our policies and provides information that we think will be helpful to you as you prepare manuscripts for submission and publication. If you have submitted a paper and want information about the status of the paper, please log in to our online manuscript submission system. If you run into any problems or if you have specific questions, you can always email us at editor@molther.org.

Editorial Evaluation Timeline

We read and evaluate every submission, and we try our best to get back to you quickly. We are mindful of how long it can take to publish a paper, so we work with authors and reviewers to minimize that time. Here’s how long each step in the process usually takes:

Initial decision to review 3–5 days after submission

Time to first decision 3–4 weeks after submission

Time suggested for revision 2–3 months

Time to online publication of accepted manuscript*

3–5 days after acceptance

Time to online publication of final proofed manuscript

3–5 weeks from acceptance

Time to print publication Within 3 months of acceptance

*This time applies to OA articles only, not subscription.

Pre-submission Inquiries

Unsure if your paper is suitable for Molecular Therapy? Send us a pre-submission inquiry at editor@molther.org, and we’ll let you know in 2–5 days what we think. Please include a title, an abstract, and an explanation of why your paper is significant and broadly interesting.

Relationship between Molecular Therapy

Journals

Co-submission

If you think your paper might be suitable for two Molecular Therapy journals, you can submit the paper for joint consideration. To do this, upload your manuscript to one of the journals. In your cover letter, please indicate that you are seeking co-consideration and mention the name of the other journal.

Transfer of Papers between Molecular Therapy Journals

Although each Molecular Therapy journal is editorially independent, we have a system that allows you to transfer your manuscript, along with the reviews and the reviewers’ identities, from one journal to another. If you have questions about the suitability of your paper for transfer, please contact the editor of the receiving journal. Often, the Editor of the receiving journal will be able to reach a decision based on the existing reviews. Occasionally, the Editor may seek comments from additional reviewers. If you use our online system to transfer your paper, you will have a chance to edit your files before they are sent to the receiving journal. You can always submit your paper to another Molecular Therapy journal without mentioning the first review process. In this case, the manuscript will be evaluated as a regular new submission.

……

更多详情：

https://marlin-prod.literatumonline.com/pb-assets/journals/society/molecular-therapy/multimedia_files-Authors_MT.pdf